Mj. Wawer et al., TRENDS IN HIV-1 PREVALENCE MAY NOT REFLECT TRENDS IN INCIDENCE IN MATURE EPIDEMICS - DATA FROM THE RAKAI POPULATION-BASED COHORT, UGANDA, AIDS, 11(8), 1997, pp. 1023-1030
Objectives: To assess whether trends in serial HIV-1 prevalence reflec
t trends in HIV incidence, and to decompose the effects of HIV-1 incid
ence, mortality, mobility and compliance on HIV-1 prevalence in a popu
lation-based cohort. Design: Two-year follow up (1990-1992) of an open
cohort of all adults aged 15-59 years, resident in a sample oi 31 rep
resentative community clusters in rural Rakai District, Uganda. Method
s: A detailed household enumeration was conducted at baseline and in e
ach subsequent year. All household residents were listed, and all deat
hs and in- and out-migrations that occurred in the intersurvey year we
re recorded. In each year, all consenting adults were interviewed and
provided a serological sample; 2591 adults aged 15-59 years were enrol
led at baseline. Results: HIV prevalence among adults declined signifi
cantly between 1990 and 1992 123.4% at baseline, 21.8% in 1991, 20.9%
in 1992; P < 0.05). Declining prevalence was also observed in subgroup
s, including young adults aged 15-24 years (from 20.6 to 16.2% over 3
years; P < 0.02), women of reproductive age (from 27.1 to 23.5%; P < 0
.05), and pregnant women (from 25.4 to 20.0%; not significant). Howeve
r, HIV incidence did not change significantly among all adults aged 15
-59 years [2.1 +/- 0.4 per 100 person-years of observation (PYO) in 19
90-1991 and 2.0 +/- 0.3 pei 100 PYO in 1991-1992], nor in population s
ubgroups. HIV-related mortality was high (13.5 per 100 PYO among the H
IV-positive), removing more infected persons than were added by seroco
nversion. Net out-migration also removed substantial numbers of HIV-po
sitive individuals. Conclusions: In this mature HIV epidemic, HIV prev
alence declined in the presence of stable and high incidence. HIV-rela
ted mortality contributed most to the prevalence decline. Prevalence w
as not an adequate surrogate measure of incidence, limiting the utilit
y of serial prevalence measures in assessing the dynamics of the HIV e
pidemic and in evaluating the impact of current preventive strategies.